NCT00589394View on ClinicalTrials.gov

Analysis of the Mechanisms of Protective Humoral Immunity in Response to the Pneumococcal Vaccine

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

January 31, 2010

Conditions
Healthy
Interventions
BIOLOGICAL

pneumococcal vaccination (Pneumovax)

pneumovax was given

Trial Locations (1)

55902

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER